These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 33045351)

  • 1. Absence of association between polymorphisms in the pfcoronin and pfk13 genes and the presence of Plasmodium falciparum parasites after treatment with artemisinin derivatives in Senegal.
    Delandre O; Daffe SM; Gendrot M; Diallo MN; Madamet M; Kounta MB; Diop MN; Bercion R; Sow A; Ngom PM; Lo G; Benoit N; Amalvict R; Fonta I; Mosnier J; Diawara S; Wade KA; Fall M; Fall KB; Fall B; Pradines B
    Int J Antimicrob Agents; 2020 Dec; 56(6):106190. PubMed ID: 33045351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of potential mediators of artemisinin resistance in African isolates of Plasmodium falciparum.
    Owoloye A; Olufemi M; Idowu ET; Oyebola KM
    Malar J; 2021 Dec; 20(1):451. PubMed ID: 34856982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal.
    Madamet M; Kounta MB; Wade KA; Lo G; Diawara S; Fall M; Bercion R; Nakoulima A; Fall KB; Benoit N; Gueye MW; Fall B; Diatta B; Pradines B
    Int J Antimicrob Agents; 2017 Jun; 49(6):754-756. PubMed ID: 28450175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local emergence in Amazonia of
    Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
    Elife; 2020 May; 9():. PubMed ID: 32394893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of novel
    Ajibaye O; Olukosi YA; Oriero EC; Oboh MA; Iwalokun B; Nwankwo IC; Nnam CF; Adaramoye OV; Chukwemeka S; Okanazu J; Gabriel E; Balogun EO; Amambua-Ngwa A
    Front Cell Infect Microbiol; 2024; 14():1366563. PubMed ID: 38716192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018-2019.
    Khan AQ; Pernaute-Lau L; Khattak AA; Luijcx S; Aydin-Schmidt B; Hussain M; Khan TA; Mufti FU; Morris U
    Malar J; 2020 Jun; 19(1):206. PubMed ID: 32513171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained
    Amambua-Ngwa A; Okebe J; Mbye H; Ceesay S; El-Fatouri F; Joof F; Nyang H; Janha R; Affara M; Ahmad A; Kolly O; Nwakanma D; D'Alessandro U
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplicon deep sequencing of kelch13 in Plasmodium falciparum isolates from Senegal.
    Gaye A; Sy M; Ndiaye T; Siddle KJ; Park DJ; Deme AB; Mbaye A; Dieye B; Ndiaye YD; Neafsey DE; Early A; Farrell T; Yade MS; Diallo MA; Diongue K; Bei A; Ndiaye IM; Volkman SK; Badiane AS; Ndiaye D
    Malar J; 2020 Mar; 19(1):134. PubMed ID: 32228566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance.
    Siddiqui FA; Boonhok R; Cabrera M; Mbenda HGN; Wang M; Min H; Liang X; Qin J; Zhu X; Miao J; Cao Y; Cui L
    mBio; 2020 Feb; 11(1):. PubMed ID: 32098812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013.
    Torrentino-Madamet M; Fall B; Benoit N; Camara C; Amalvict R; Fall M; Dionne P; Ba Fall K; Nakoulima A; Diatta B; Diemé Y; Ménard D; Wade B; Pradines B
    Malar J; 2014 Dec; 13():472. PubMed ID: 25471113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.
    Muwanguzi J; Henriques G; Sawa P; Bousema T; Sutherland CJ; Beshir KB
    Malar J; 2016 Jan; 15():36. PubMed ID: 26801909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal.
    Diallo MA; Yade MS; Ndiaye YD; Diallo I; Diongue K; Sy SA; Sy M; Seck MC; Ndiaye M; Dieye B; Gomis JF; Sow D; Dème AB; Badiane AS; Ndiaye D
    Sci Rep; 2020 Jun; 10(1):8907. PubMed ID: 32483161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.
    Bakhiet AMA; Abdelraheem MH; Kheir A; Omer S; Gismelseed L; Abdel-Muhsin AA; Naiem A; Al Hosni A; Al Dhuhli A; Al Rubkhi M; Al-Hamidhi S; Gadalla A; Mukhtar M; Sultan AA; Babiker HA
    Trans R Soc Trop Med Hyg; 2019 Nov; 113(11):693-700. PubMed ID: 31369106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.
    Atroosh WM; Al-Mekhlafi HM; Snounou G; Al-Jasari A; Sady H; Nasr NA; Lau YL; Surin J
    Malar J; 2016 May; 15(1):295. PubMed ID: 27234587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and Lumefantrine.
    van Schalkwyk DA; Pratt S; Nolder D; Stewart LB; Liddy H; Muwanguzi-Karugaba J; Beshir KB; Britten D; Victory E; Rogers C; Millard J; Brown M; Nabarro LE; Taylor A; Young BC; Chiodini PL; Sutherland CJ
    Clin Infect Dis; 2024 Feb; 78(2):445-452. PubMed ID: 38019958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status of Artemisinin Resistance in Malaria Parasite
    Oboh MA; Ndiaye D; Antony HA; Badiane AS; Singh US; Ali NA; Bharti PK; Das A
    Biomed Res Int; 2018; 2018():2305062. PubMed ID: 30402465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum Kelch Propeller Polymorphisms in Clinical Isolates from Ghana from 2007 to 2016.
    Matrevi SA; Opoku-Agyeman P; Quashie NB; Bruku S; Abuaku B; Koram KA; Fox A; Letizia A; Duah-Quashie NO
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Epidemiology of Plasmodium falciparum kelch13 Mutations in Senegal Determined by Using Targeted Amplicon Deep Sequencing.
    Talundzic E; Ndiaye YD; Deme AB; Olsen C; Patel DS; Biliya S; Daniels R; Vannberg FO; Volkman SK; Udhayakumar V; Ndiaye D
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis.
    WWARN K13 Genotype-Phenotype Study Group
    BMC Med; 2019 Jan; 17(1):1. PubMed ID: 30651111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana.
    Ahorhorlu SY; Quashie NB; Jensen RW; Kudzi W; Nartey ET; Duah-Quashie NO; Zoiku F; Dzudzor B; Wang CW; Hansson H; Alifrangis M; Adjei GO
    Malar J; 2023 Feb; 22(1):58. PubMed ID: 36803541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.